These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 15801544

  • 1. In vitro metabolism of quazepam in human liver and intestine and assessment of drug interactions.
    Miura M, Ohkubo T.
    Xenobiotica; 2004; 34(11-12):1001-11. PubMed ID: 15801544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
    Sugimoto K, Araki N, Ohmori M, Harada K, Cui Y, Tsuruoka S, Kawaguchi A, Fujimura A.
    Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305
    [Abstract] [Full Text] [Related]

  • 4. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
    Hyland R, Roe EG, Jones BC, Smith DA.
    Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070
    [Abstract] [Full Text] [Related]

  • 5. Interaction study between fluvoxamine and quazepam.
    Kanda H, Yasui-Furukori N, Fukasawa T, Aoshima T, Suzuki A, Otani K.
    J Clin Pharmacol; 2003 Dec; 43(12):1392-7. PubMed ID: 14615476
    [Abstract] [Full Text] [Related]

  • 6. Effects of itraconazole on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug.
    Kato K, Yasui-Furukori N, Fukasawa T, Aoshima T, Suzuki A, Kanno M, Otani K.
    Ther Drug Monit; 2003 Aug; 25(4):473-7. PubMed ID: 12883232
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD, Schmitz A, Theurillat R, Thormann W, Mevissen M.
    Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Excretion of quazepam into human breast milk.
    Hilbert JM, Gural RP, Symchowicz S, Zampaglione N.
    J Clin Pharmacol; 1984 Oct; 24(10):457-62. PubMed ID: 6150944
    [Abstract] [Full Text] [Related]

  • 12. Relationships of brain and plasma levels of quazepam, flurazepam, and their metabolites with pharmacological activity in mice.
    Hilbert JM, Iorio L, Moritzen V, Barnett A, Symchowicz S, Zampaglione N.
    Life Sci; 1986 Jul 14; 39(2):161-8. PubMed ID: 3724367
    [Abstract] [Full Text] [Related]

  • 13. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
    Gentile DM, Verhoeven CH, Shimada T, Back DJ.
    J Pharmacol Exp Ther; 1998 Dec 14; 287(3):975-82. PubMed ID: 9864282
    [Abstract] [Full Text] [Related]

  • 14. Multiple-dose quazepam kinetics.
    Chung M, Hilbert JM, Gural RP, Radwanski E, Symchowicz S, Zampaglione N.
    Clin Pharmacol Ther; 1984 Apr 14; 35(4):520-4. PubMed ID: 6705450
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4.
    Renwick AB, Lewis DF, Fulford S, Surry D, Williams B, Worboys PD, Cai X, Wang RW, Price RJ, Lake BG, Evans DC.
    Xenobiotica; 2001 Apr 14; 31(4):187-204. PubMed ID: 11465405
    [Abstract] [Full Text] [Related]

  • 16. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
    Kong TY, Kim JH, Choi WG, Lee JY, Kim HS, Kim JY, In MK, Lee HS.
    Anal Bioanal Chem; 2017 Feb 14; 409(6):1667-1680. PubMed ID: 27924364
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.
    Oda Y, Kharasch ED.
    J Pharmacol Exp Ther; 2001 Sep 14; 298(3):1021-32. PubMed ID: 11504799
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.